Início › Câncer de Pulmão › Ohio › Cincinnati
Ensaios clínicos de Câncer de Pulmão em Cincinnati, OH
19 estudos para Câncer de Pulmão estão buscando participantes em locais em Cincinnati e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- e mais 3
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecrutandoFase 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · a 15 mi de distância
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
RecrutandoFase 3
- University of Cincinnati Cancer Center, Cincinnati
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RecrutandoFase 3
- TriHealth Cancer & Blood Institute Research, Cincinnati
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RecrutandoFase 3
- Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0061), Edgewood · a 8 mi de distância
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecrutandoFase 3
- Oncology Hematology Care Clinical Trials, Cincinnati
- Oncology Hematology Care Clinical Trials, Cincinnati
- Oncology Hematology Care Clinical Trials, Cincinnati
- e mais 1
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RecrutandoFase 2/3
- The Christ Hospital Cancer Center, Cincinnati
- University of Cincinnati Medical Center, Cincinnati
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
RecrutandoFase 1/2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · a 15 mi de distância
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecrutandoFase 3
- USO - Oncology Hematology Care, Cincinnati
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
RecrutandoFase 3
- The Christ Hospital Cancer Center, Cincinnati
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RecrutandoFase 1
- Xencor Investigative Site, Cincinnati
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
RecrutandoFase 2
- University of Cincinnati Medical Center, Cincinnati
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
RecrutandoFase 1/2
- University of Cincinnati, Cincinnati
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- The Christ Hospital, Cincinnati
MYLUNG Consortium Part 3: Observational Study
RecrutandoEstudo observacional
- Oncology Hematology Care Clinical Trials, LLC, Cincinnati
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecrutandoFase 1/2
- Christ Hospital Cancer Center, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Cincinnati
A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
RecrutandoFase 2
- The Christ Hospital, Cincinnati
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
RecrutandoEstudo observacional
- University of Cincinnati, Cincinnati
Ensaios de Câncer de Pulmão em outras cidades
- Houston, TX78 estudos
- Boston, MA62 estudos
- New York City, NY60 estudos
- Los Angeles, CA45 estudos
- Washington, DC41 estudos
- Arlington, VA41 estudos
- Chicago, IL41 estudos
- Nashville, TN40 estudos
- Baltimore, MD40 estudos
- St. Louis, MO39 estudos
- Columbus, OH37 estudos
- Philadelphia, PA36 estudos
Outros estudos em Cincinnati
- Câncer de Pulmão de Não Pequenas Células35 estudos
- Câncer (todos os tipos)27 estudos
- Câncer de Mama25 estudos
- Insuficiência Cardíaca24 estudos
- Câncer Colorretal21 estudos
- Leucemia Mieloide Aguda20 estudos
- Câncer Metastático20 estudos
- Câncer de Ovário19 estudos
- Obesidade19 estudos
- Câncer de Próstata18 estudos
- Mieloma Múltiplo17 estudos
- Melanoma17 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.